22:55 IST
NSE
Regulatory ApprovalCipla Ltd CIPLA
Cipla Regulatory Approval
Cipla received U.S. FDA approval for its Generic Advair Diskus. The product is expected to launch in the U.S. market in Q2 FY 2026-27.
Cipla regulatory approval announcements
Every Cipla regulatory approval announcement on NSE and BSE, newest first, each with its own page.
Time
1 announcement with these filters